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There is a current need for enhancing our insight in the effects of antimicrobial treatment
on the composition of human microbiota. Also, the spontaneous restoration of the
microbiota after antimicrobial treatment requires better understanding. This is best
addressed in well-defined animal models. We here present a model in which immunecompetent or neutropenic mice were administered piperacillin-tazobactam (TZP) according
to human treatment schedules. Before, during and after the TZP treatment, fecal specimens
were longitudinally collected at established intervals over several weeks. Gut microbial
taxonomic distribution and abundance were assessed through culture and molecular
means during all periods. Non-targeted metabolomics analyses of stool samples using
Quadrupole Time of Flight mass spectrometry (QTOF MS) were also applied to determine
if a metabolic fingerprint correlated with antibiotic use, immune status, and microbial
abundance. TZP treatment led to a 5–10-fold decrease in bacterial fecal viability counts
which were not fully restored during post-antibiotic follow up. Two distinct, relatively uniform
and reproducible restoration scenarios of microbiota changes were seen in post
TZP-treatment mice. Post-antibiotic flora could consist of predominantly Firmicutes or,
alternatively, a more diverse mix of taxa. In general, the pre-treatment microbial communities
were not fully restored within the screening periods applied. A new species, closely related
to Eubacterium siraeum, Mageeibacillus indolicus, and Saccharofermentans acetigenes,
became predominant post-treatment in a significant proportion of mice, identified by 16S
rRNA gene sequencing. Principal component analysis of QTOF MS of mouse feces
successfully distinguished treated from non-treated mice as well as immunocompetent
from neutropenic mice. We observe dynamic but distinct and reproducible responses in
the mouse gut microbiota during and after TZP treatment and propose the current murine
model as a useful tool for defining the more general post-antibiotic effects in the gastrointestinal ecosystem where humanized antibiotic dosing may ultimately facilitate
extrapolation to humans.
Keywords: humanized antibiotic treatment, piperacillin-tazobactam, non-infected mouse model, microbiome
dynamics, metabolome, gastro-intestinal tract
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INTRODUCTION

perturbations, and variations in the microbiome composition
from one person to the next.
Here, we advocate an approach that uses a more standardized
longitudinal murine model to study the effect of humanizeddosing of piperacillin-tazobactam (TZP) on the gut microbiome
in a controlled physiological environment (Bulik and Nicolau,
2010; Bulik et al., 2012). We used TZP because its pharmacokinetic
and pharmacodynamic (PK/PD) characteristics in humans are
well-known. In addition, TZP is a frequently used beta-lactam/
beta-lactamase inhibitor combination. The use of dosing schemes
meant to mimic the PK/PD of antibiotics in humans improves
the translational value of the murine model since historic
approaches use drug exposures that are not achieved in humans
and, therefore, not clinically useful (Gill et al., 2020). We
performed a taxonomic survey of the mouse fecal microbiome
using 16S rRNA gene sequencing before, during and after TZP
treatment. This study showed the bacterial taxa present in terms
of percentages as well as the quantitative bacterial load, which
was more precisely defined using quantitative PCR (qPCR). In
addition, we performed metabolomic studies and defined the
parallel between microbiological variation and the (im)balance
within the metabolome.

Antimicrobial agents are crucial for protection against and
cure of infectious processes. Many different categories of
antibiotics have been developed to date and most have found
limited or prolonged success. Currently, overall antibiotic
effectivity seems to be waning due to the global development
of antimicrobial resistance (AMR) and a reduced developmental
pipeline for new antibiotics (D’Atri et al., 2019). This trend is
worrisome and one that needs vigorous attention. There is a
need for alternative approaches next to the purely (bio-)chemical
ones that have dominated. The use of bacteriolytic enzymes,
clever nucleic acid constructs, or bacteriophages for combatting
infections are currently being examined as alternative approaches
that target specific pathogenic species and spare colonizing
bacterial populations present in human microbiota and not
involved in the actual disease process (Gordillo Altamirano
and Barr, 2019; López-Jácome et al., 2019). In the meantime,
the effect of antibiotic treatment on mixed bacterial
populations needs further clarification (Galera-Laporta and
Garcia-Ojalvo, 2020).
Recently, our knowledge on the nature of the human
microbiomes has been systematically improved and its overall
relevance to health is now an accepted paradigm (Schloissnig
et al., 2013; Sunagawa et al., 2014). A healthy and diverse
gastro-intestinal bacterial flora, for instance, has been suggested
to provide a natural barrier against infection (Sassone-Corsi
and Raffatellu, 2015). Hence, fecal transplantation is an alternative
means to curing certain infections by repairing the stasis of
the patient’s microbiome. Still, the Yin-Yang effects of antibiotic
use vs. targeted microbiome interventions, or their combination
is an emerging science and detailed mechanistic and therapeutic
studies have yet to be completed.
In addition to targeting pathogens, antibiotics also alter
the resident commensal intestinal microbiota, often resulting
in a dysbiotic gut microbiome. These effects are host dependent
and may have differing influences on individual metabolic
processes (Fujisaka et al., 2016). Antibiotic treatment may
help selectively amplify certain sub-populations of potentially
pathogenic bacterial species and/or enrich antibiotic resistance
genes within the population (Ubeda et al., 2010; Meletiadis
et al., 2017; Richter et al., 2018; Burdet et al., 2019; Haak
et al., 2019). Antibiotics can promote disease by themselves
(antibiotic-associated diarrhea, for instance; Rashid et al.,
2015) and protection from those unwanted side effects are
important, possibly through microbiome-mediated interventions
(Becattini et al., 2017; De Gunzburg et al., 2018). Overall,
antimicrobial agents can potentially affect the stability and
complexity of microbiomes in both the short- and long-term.
More detailed studies are required to define whether antibioticinduced disturbance of microbiomes can be normalized once
therapy has been discontinued. So called dysbiome or dysbiosis
studies have revealed novel associated pathologies (Carding
et al., 2015; Gilbert et al., 2018; Janssens et al., 2018). Studying
the effects of antibiotics on the microbiome is complicated
in the very diverse human ecosystem, including the added
variations of human diet, host genetics, prior microbiome
Frontiers in Microbiology | www.frontiersin.org

MATERIALS AND METHODS
Immune-Competent Uninfected Animal
Model

Two experiments were conducted in which TZP was administered
to mice in a “humanized” dosing regimen. The first pilot
experiment (TZP1) consisted of 6 days pre-TZP monitoring
(including 48 h of acclimation after arrival to the vivarium
from the vendor), 7 days of TZP treatment, and 7 days post-TZP
treatment follow-up. After conducting preliminary analyses on
the fecal pellets from this experiment, we designed a second
experiment (TZP2) in which two sets of mice, immunocompetent
and neutropenic, were allowed a 14-day pre-TZP time period,
to observe bacterial community changes during the acclimation
period, followed by 4 days of TZP exposure using the humanized
dosing regimen, and 21 days of post-antibiotic recovery period.
For each experiment, 10 specific-pathogen-free, female ICR
(CD-1) mice weighing between 20 and 22 g upon delivery
were obtained from Envigo RMS, Inc. (Indianapolis, Indiana).
In the second experiment, 10 neutropenic mice were included
as well (see below in section “Neutropenic Uninfected Animal
Model”). Upon receipt from the vendor, animals were housed
individually to prevent the exchange of genetic material through
the consumption of fecal droppings. All animals were provided
food and water ad libitum. After the 48-h acclimation period,
fecal pellets were collected from each mouse over a period
of 2 h (Day 2) during which each mouse was individually
housed in a box without bedding, food, or water. After fecal
pellet collection, mice were placed into new individual cages.
Pellets for culture (first experiment only) were placed into
Copan liquid Amies Elution tubes (Copan Italia, Brescia, Italy)
for collection and transport and stored at 4°C–8°C until
transport to the Jackson Laboratory, where they were again
2
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stored at 4°C until culture. Pellets for microbiome analysis
were stored at −80°C until transport to the Jackson Laboratory
on dry ice, where they were then stored at −80°C. Additionally,
pellets were collected and stored at −80°C to be assayed for
TZP concentrations. Fecal collection was repeated at the end
of days 6, 9, 13, and 20 for TZP1 and daily (days 0–39) for
TZP2. Animals were euthanized using CO2 and cervical
dislocation at the end of the study period.

and high quality control samples (n = 10) were 3.2 and 2.4%,
respectively. Inter-day coefficients of variation were 6.0 and
5.0%, respectively (n = 7).

16S Microbiome Sequencing and
Operational Taxonomic Unit Generation

DNA was extracted from stool specimens using the MoBio
PowerSoil DNA Isolation Kit (Carlsbad, United States). Targeted
amplification of the V1–V3 hypervariable region of the 16S
rRNA gene was performed with primers 27F (5′-AGAGTTTGAT
CCTGGCTCAG-3′) and 534R (5′-ATTACCGCGGCTGCTGG-3′)
using AccuPrime Taq DNA Polymerase High Fidelity (Invitrogen,
Waltham, United States) and 4 ng of template DNA in a total
reaction volume of 20 μl. The PCR was run using the following
cycling parameters: 2 min of denaturation at 95°C, followed
by 30 cycles of 20 s at 95°C, 30 s at 56°C, and 1 min at 72°C.
The presence of amplicons was confirmed by agarose gel
electrophoresis and staining with GreenGlo Safe DNA Dye
(Thomas Scientific, Santa Clare, CA, United States). The
concentrations of amplicons were quantified by Qubit dsDNA
HS Kit (Invitrogen), and then equimolar amounts (4 nM) of
the PCR amplicons were pooled in a single tube. Short DNA
fragments and amplification primers were removed from the
pooled amplicons using AMPure XP beads (Beckman-Coulter,
Indianapolis, IN, United States), and subsequently sequenced
using 2 × 300 base-pair paired-end sequencing (Illumina MiSeq;
Illumina, San Diego, United States). Proprietary Illumina software
was applied to perform initial processing of raw sequencing
data, removing barcodes and primers. A standard of one
mismatch in primer and zero mismatch in barcode was applied
to assign read pairs to the appropriate sample in a pool of
samples. Adapters and low-quality bases were trimmed using
Trimmomatic (Bolger et al., 2014), paired end sequences were
assembled with FLASH (Magoč and Salzberg, 2011), and
chimeras were removed with UCHIME (Edgar et al., 2011).
Mouse contaminant sequences were filtered out using BMTagger
(Lee and Shatkay, 2006). The resulting sequences were clustered
into 97% similarity operational taxonomic units (OTUs) using
USEARCH v10.0.240 (Wang et al., 2007; Edgar et al., 2011),
and final taxonomic assignment was performed using the RDP
Classifier (Wang et al., 2007). OTUs containing mitochondrial
sequences were identified by BLAST (Camacho et al., 2009)
against a local database of bacterial and mitochondrial RefSeq 16S
sequences downloaded from NCBI GenBank on January 25,
2019. OTUs where the reference sequence had >97% identity
and >97% query coverage to a mitochondrial sequence were
removed from further analysis.
In several cases, the partial V1–V3 16S rRNA gene sequence
indicated that a single bacterial species was predominant in
the specimen. We directly sequenced the entire V1–V9 16S
rRNA gene (Johnson et al., 2019; primers 27F, AGAGTTTGATCM
TGGCTCAG, and 1492R, TACGGYTACCTTGTTAYGACTT)
from such stools at the antibiotic treatment time point for
three mice: mouse 6 in TZP1, and mice 9 (immunocompetent)
and 19 (neutropenic) from TZP2. The high-quality reads from
these three samples were pooled and OTUs were formed. The
10 OTUs with the most reads assigned were then matched

Neutropenic Uninfected Animal Model

TZP2 included 10 immunocompetent and 10 neutropenic mice.
For the neutropenic model, 10 mice were housed individually,
and fecal samples were collected daily as described above for
the immunocompetent uninfected animal model, except that
the mice were rendered transiently neutropenic by injecting
cyclophosphamide intra-peritoneally (IP) at a dose of 250 mg/
kg of body weight at 4 days and 100 mg/kg 1 day before antibiotic
dosing began. Transient neutropenia lasts for about 10–11 days
as based on long-lasting experience at Jackson Laboratories.

Human-Simulated Dosing Regimen

Commercially available TZP was obtained from Cardinal Health
(Dublin, OH). Dosing solutions were prepared in sterile 0.9%
normal saline. All dosing solutions were held on ice, protected
from light throughout the dosing period. The mice received
the following TZP dosing regimen subcutaneously to achieve
exposures comparable to those achieved in humans: 500/62.5 mg/
kg at 0 h, 100/12.5 mg/kg at 0.25 h, 200/25 mg/kg at 2.5 h, and
75/9.375 mg/kg at 5 h (Bulik et al., 2012). This dosing regimen
was repeated every 6 h for the duration of the antibiotic exposure
portion of the experiment (TZP1: Days 7–13, TZP2: Days 15–18).

Determination of Piperacillin Content in
Murine Feces

Piperacillin concentrations were determined using a validated
high-performance liquid chromatography (HPLC) assay, modified
from a previously reported method (Kim et al., 2002), at the
Center for Anti-Infective Research and Development (CAIRD),
Hartford Hospital. The mobile phase consisted of 0.1 M phosphate
buffer pH 2.7 with 29.8% acetonitrile (ACN). The standards
and quality control samples were prepared in pooled mouse
feces matrix. Mouse feces samples were weighed and a mixture
of methanol, water, and acetic acid (40:40:1) was added to
achieve a 1:8 dilution. An internal standard of 20 μl of 2,500 μg/
ml penicillin G (Sigma, St. Louis, MO) and stainless steel
3.2 mm beads (Biospec Products Bartlesville, United Kingdom)
were added, the sample was vortexed then centrifuged, and
the supernatant was assayed for piperacillin content. The HPLC
system consisting of a Waters 515 pump (Waters Associates,
Milford, MA, United States) and a 717 plus auto-sampler
(Waters) was equipped with a 10 μm Prodigy C18 column
(4.6 mm × 250 mm, Phemonenex Inc., Torrance, CA,
United States) coupled to a Bondapak C18 Guard-pak pre-column
(Waters). A programmable UV detector (Model 526; ESA Inc.,
Chelmsford, MA) set at 230 nm for 23 min was used to detect
the analytes. The lower limit of quantification was 16 μg/g of
feces. Optimized intraday coefficients of variation for the low
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against the GenBank RefSeq collection using BLAST to find
the closest hits (the nearest match was ~84%). Those closest
hits were used to build a phylogenetic tree using the neighborjoining method.

was added at 50 mg/ml of feces/MeOH. After extraction, sample
vials were centrifuged at 14,000 rpm for 5 min to settle particles.
Aliquots of 100 μl supernatant were placed in a clean 1.5 ml
vial. Samples were then rotovapped to dryness at 45°C for
60 min, then reconstituted in 100 μl of 0.1% formic acid water
with 500 ng/ml reserpine for QTOF analysis (see below).

Bacterial Culturing

To identify any low- or high-level TZP resistant aerobic organisms,
liquid from each Copan transport tube was plated onto
CHROMID agar (bioMérieux, Durham, NC, United States)
with 4/4 μg/ml or 64/4 μg/L TZP, respectively, and incubated
at 37°C for up to 5 days. TZP-resistant Escherichia coli strain
907355 was used as a positive control (Schechter et al., 2018).
This method will not identify anaerobes or susceptible strains
that were protected by other mechanisms when in the gut
microbial community.

Instrumentation

Samples were analyzed by a HPLC Quadrupole Time of Flight
mass spectrometry (QTOF MS) applying Electrospray Ionization
(ESI). Separation was performed by reverse-phase chromatography
using an Agilent 1260 instrument (Santa Clara, CA, United States).
MS analysis was carried out by a SCIEX QTOF 5600 mass
spectrometer with a Sciex DuoSpray™ ion source (Concord,
Ontario Canada). The auto-sampler was operated in partial loop
injection mode with an injection volume of 10 μl. After injection,
LC flow was bypassed for 3 min with a VICI bypass valve (Houston,
TX, United States) before switching to the analytical column. For
positive ion mode acquisition, analytes were eluted using a 2%–90%
gradient organic solute in 17 min followed by a 5 min hold at
90%, then a 6 s return to 2% organic holding for 5 min to
re-equilibrate the column. A flow rate of 0.2 ml/min was employed
using 0.1% formic acid/water for the aqueous phase and 0.1%
formic acid/ACN for the organic phase. For negative ion mode
acquisition, analytes were eluted using a 2%–90% gradient organic
in 9.5 min followed by a 150 s hold at 90%, then a 6 s return to
2% organic, held for 144 s to re-equilibrate the column. A flow
rate of 0.5 ml/min was achieved using 5.4 mM ammonium acetatewater for the aqueous phase and ACN for the organic phase.
Mass spectra and tandem mass spectra were recorded in
both positive- and negative-ion modes with the “high-sensitivity”
mode selected. A TOF scan from 75 to 1,000 Daltons (Da)
was performed involving four time-bins and all four time-todigital converter (TDC) channels selected. Information dependent
acquisition (IDA) was set to trigger MS/MS product ion scans
when the signal exceeded 100 counts/s (CPS), whereas dynamic
accumulation was on and a maximum of six dependent candidate
ions were scanned per cycle.

Quantitative PCR

Quantitative PCR was carried out using SYBR Green reagents
and protocols (Green and Sambrook, 2018). DNA was first
diluted to between 0.001 and 1.0 ng/μl to optimize detection
of differences in bacterial loads between samples. The master
mix of SYBR Green reagents and primer was created by
combining 12.5 μl of SYBR Green and 7.5 μl of primer for
each reaction. A total of 20 μl of the master mix was added
and 5 μl of the diluted DNA was added to each well of the
reaction plate to make a total reaction volume of 25 μl. Primers
used in these experiments are found in Table 1 and target
the 16S rRNA gene. The Viia 7 Real-Time PCR machine (Life
Technologies, Carlsbad, CA, United States) carried out the
reaction with SYBR Green Fast reagents and comparative Ct
analysis. Each qPCR was run with 40 cycles, with each cycle
running at 95°C for 1 s and 45°C for 45 s.

Mass Spectrometry Sample Preparation

Pelleted mouse feces were shipped on ice to the mass spectrometry
facility, where they were stored at −20°C. Samples were then
lyophilized using a Labconco Rotovap, and dry feces were
weighed using a Metler Toledo XPE206 analytical balance. Postlyophilization, samples were returned to the freezer until extraction.
Several extraction solvents were tested including 100% methanol
(MeOH), 40% MeOH-40% ACN-20% distilled water, and 80%
MeOH-20%ACN in 1.5 ml glass bead vials. Neat methanol was
found to be the best, so the lyophilized mouse feces were
homogenized using 100% MeOH. Homogenization was performed
manually using a pestle and mortar procedure. Extraction volume

HPLC QTOF MS Run Sequence

A typical run sequence began with two double blank injections
to condition the system, followed by six consecutive injections
of 500 ng/ml reserpine to define system suitability. Sequence
order of sample analysis was randomized using Microsoft Excel.
Instrument calibration was performed every 10 samples (5 h)

TABLE 1 | Quantitative PCR (qPCR) primers utilized in this study.

Universal
Bacteroidetes
Firmicutes
Gammaproteobacteria
OTU-1 Clostridiales

Forward primer 5'–3'

Reverse primer 5'–3'

Citation

TCCTACGGGAGGCAGCAGT
CRAACAGGATTAGATACCCT
TGAAACTYAAAGGAATTGACG
TCGTCAGCTCGTGTYGTGA
GGTTTGAAGGCATCTTCTTTCC

GGACTACCAGGGTATCTAATCCTGTT
GG TAAGG TTCCTCGCGTAT
ACCATGCACCACCTG TC
CGTAAGG GCCATGATG
GTTAGCCGAGGCTTATTCCTAA

Nadkarni et al., 2002
De Gregoris et al., 2011
De Gregoris et al., 2011
De Gregoris et al., 2011
This Study

Primer names, forward, and reverse sequences are shown for each primer set. Relevant publications are listed for all except the operational taxonomic unit (OTU)-1 Clostridiales
primers, which were designed for this study.
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using the Sciex Calibration Delivery System with Sciex APCI
positive calibration solution part #4460131 for positive mode
acquisition and Sciex APCI negative calibration solution part
#4460134 for negative mode acquisition.

OTUs using cross_match v1.090518 and rates of substitution,
deletion, and insertion errors calculated. Total error was calculated
by the substitution, deletion, and insertion errors. Using an
exponential decay function, CCS pass numbers were modeled
against the total error rate and a CCS pass cutoff that gave
less than a 2.3% error rate for the 95th percentile of the data
was selected. Sequence reads below this CCS pass threshold
were subsequently removed from each group. Data from mouse
6 required nine CCS passes to get 95% of the data to below
2.3% total error while mice 9 and 19 required seven CCS passes.

Full-Length 16S Sequences

Fecal samples were selected from mouse 6, Day 9 from TZP1,
and mice 9 (immune-competent) and 19 (neutropenic), Day
18 from TZP2 in which the Clostridiales OTU (OTU-1 and
-3 in TZP1 and TZP2, respectively) was present at >95% relative
abundance. DNA was extracted from stool using a Qiagen
extraction kit (QIAGEN, Hilden, Germany), and 1 μg DNA
was used as template to prepare SMRTbell libraries. DNA was
sheared using Covaris g-tubes at 4,000 rpm for 3–4 min and
cleaned using 0.75X AmPure XP beads to size select the desired
range of fragments and remove all DNA fragments <200 bp.
PacBio sequencing libraries were prepared using the SMRTbell
template prep kit 1.0 (Pacific Biosciences, Menlo Park, CA,
United States) according to the manufacturer’s protocol. Quality
assessment of libraries was performed using the Qubit
Fluorometer (Thermofisher) and the TapeStation (Agilent, Santa
Clara, CA, United States). Loading protocols for each sample
were made using PacBio SMRTLink v 6.0. Libraries were
annealed to Conditioned Sequencing Primer v3.0 then bound
to Sequel Polymerase v3.0 in accordance with SMRTLink
directions. Libraries then underwent a Qubit, AMPure PB
cleanup and a second Qubit run. Based on the final Qubit
analysis, libraries were diluted and Internal Control v3.0 was
added to each sample. Final libraries were loaded onto the
Sequel according to SMRTLink directions. Libraries were run
at 6 pm with Sequencing Kit 3.0 V2 and SMRTcells v3.0.
Immobilization time was set at 120 min, Pre-Extension was
set at 120 min and Movie Time was set at 600 min for each
SMRTcell. Output files were processed and assembled into
circular consensus sequencing (CCS) reads using PacBio Sequel
SMRTLink-Release_7.0.0.63985 software default settings with
minimum passes to 3 and minimum predicted accuracy to
0.9. Sequence orientation was assessed and, if necessary, corrected
using the orient command in USEARCH v10.0.240 with the
GreenGenes database v13_5 as a reference. Sequences between
900 and 1,800 bp were kept for further analysis.

Phylogenetic Tree Placement

In order to identify the likely taxonomy of the V1–V3 Clostridiales
OTUs present after antibiotic treatment, each OTU was first
matched to full-length 16S rRNA gene sequences generated
as described above. Subsequently, a phylogenetic tree was built
using matched PacBio full-length 16S rRNA gene sequences
and their closest full-length 16S homologues present in the
NCBI 16S Refseq database. Full-length PacBio 16S rRNA gene
sequences remaining after the CCS pass filtering described
above were pooled to combine the sequences generated from
mouse 6 with those generated from mice 9 and 19. Pooled
sequences were then de-replicated and filtered using the
USEARCH “derep_fulllength” command to retain only unique
sequences represented five or more times. Remaining sequences
were indexed using the “makeblastdb” command in BLAST+
v2.6.0. Representative V1–V3 OTU Clostridiales sequences were
searched against the resulting databases to identify all occasions
where a V1–V3 sequence was an exact match to one or more
full-length 16S sequences. In total, 10 full-length 16S gene
sequences matched the V1–V3 OTUs with 100% identity across
100% of the V1–V3 sequence.

Identification of the 16S rRNA Gene OTU

In order to identify the likely taxonomy of the 10 candidate
full-length 16S rRNA gene sequences, each sequence was
aligned to the NCBI 16S RefSeq database (download 27 June
2019) using the “blastn” (BLAST+ v2.6.0) command with the
option “max_target_seqs” set to 500 (Madden et al., 2019).
Matching target sequences were then sorted by e-value, followed
by bitscore, and the top 100 best matches for each query
sequence were combined. After removing duplicate matches,
this resulted in 182 unique NCBI 16S RefSeq sequences with
homology to one or more of our 10 query sequences. The
182 RefSeq 16S rRNA gene sequences and 10 query sequences
were pooled and aligned against the GreenGenes reference
database using PyNAST v0.1 (Caporaso et al., 2010). PyNAST
was run using the QIIME (v1.9.0) script “align_seqs.py” with
a minimum of 75% identity. During PyNAST alignment of
the RefSeq 16S sequences, one sequence had only ~83% mean
identity to the reference alignment and was removed from
further analysis. The resulting alignment was visually assessed
on SeaView v4.7 (Gouy et al., 2010; Carretero-Paulet and
Albert, 2016) during which nine additional RefSeq 16S rRNA
gene sequences were removed due to disproportionately short
length or poor alignment. The remaining 182 sequences

Sequence Cleaning and Annotation

Initial examination of sequence data indicated very high sequence
diversity (even in samples that were assumed to contain very
few taxa). Therefore, to account for the possibility that such
diversity was driven by sequencing error, additional filtering
steps were applied as described hereafter. Sequences were initially
processed separately for data from mouse 6, but combined
for data generated from mice 9 and 19 as their 16S rRNA
gene V1–V3 region sequences clustered into the same 97%
OTU. Sequences from each group were de-replicated and
clustered into OTUs with 97% similarity using USEARCH
fastx_uniques and cluster_otus commands with default settings.
Reads from each group (mouse 6, mice 9/19) were then
aligned to the representative sequences for their respective
Frontiers in Microbiology | www.frontiersin.org
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Assessment of Gastro-Intestinal Bacterial
Loads Before, During, and After TZP
Treatment

(including the 10 sample sequences) were trimmed at positions
68–1,907 and empty columns were removed by Splicer v3
(Srivastava et al., 2017). Aligned sequences were subsequently
processed using the QIIME script “filter_alignment.py,” using
a gap filter threshold of 0.95. Finally, a Neighbor-Joining tree
was constructed using FastTree v2.1.3 (Price et al., 2009) via
the QIIME script “make_phylogeny.py.” The tree was visualized
using the ggtree package v1.14.6 in R v3.5.1 (R Core Team,
2013; Yu et al., 2018).

Quantitative PCR was performed to quantify the bacterial load
using universal 16S rRNA primers as well as phylum-specific
primer sets (Table 1; Figure 1; Supplementary Figure 1;
Nadkarni et al., 2002; De Gregoris et al., 2011). Bacterial loads
for each mouse at each time point were compared by calculating
the fold change in 16S rRNA amplicons with respect to the
last pre-antibiotic time point (day 6 and 14 in TZP1 and
TZP2, respectively). The overall bacterial loads in both
experiments decreased upon antibiotic exposure, up to 5–10fold, and began to increase again upon termination of the
antibiotic administration, though the bacterial loads in both
experiments did not return to their respective pre-antibiotic
levels. The Bacteroidetes-specific primers showed that
Bacteroidetes decreased up to 10–15-fold upon exposure to
TZP and remained low even 2 weeks after termination of TZP,
possibly indicating more permanent changes. Firmicutes and
Gammaproteobacteria were the first to recover in terms of
bacterial load. The dynamics observed here suggest different
antibiotic-induced scenarios for different phyla of bacteria. Of
note, there do not seem to be major differences at this level
between immune-competent and neutropenic mice.

RESULTS
To understand the effects of antibiotic treatment on the gut
microbiome, two experiments were conducted in which TZP
was administered to mice in a dosing regimen designed to
mimic the human clinical dosing levels (Bulik et al., 2012).
TZP1 consisted of 6 days pre-TZP monitoring (including 48 h
of acclimation after arrival to the vivarium from the vendor),
7 days of TZP treatment, and 7 days post-TZP treatment follow-up.
After conducting preliminary analyses on the fecal pellets from
this experiment, we designed a second experiment, TZP2, in
which two sets of 10 mice, immunocompetent as well as
neutropenic, were allowed a 14-day pre-TZP time period, to
observe bacterial community changes during the acclimation
period, followed by 4 days of TZP exposure using the humanized
dosing regimen, and 21 days of post-antibiotic recovery period.
The neutropenic model is important since TZP is often used
a therapeutic agent in neutropenic human patients.

Changes in Bacterial Community
Composition

The bacterial communities were monitored by targeted sequencing
of the V1–V3 variable regions of the 16S rRNA genes. Key

FIGURE 1 | Bacterial quantification of the TZP2 experiment. Box and whiskers plots show the fold change of the 16S rRNA gene count as generated by
quantitative PCR (qPCR) from DNA extracted from stool for all mice (immunocompetent and neutropenic shown separately) at each time point as compared to Day
14, the time-point immediately prior to antibiotic treatment.
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time points were chosen before, during, and after TZP
administration. Sequence reads were clustered into OTUs based
on at least 97% sequence identity. The relative abundance of
these OTUs formed a taxonomic profile for each time point
for each mouse. A principal coordinate analysis (PCoA) based
on the Bray-Curtis distance matrix shows the similarity of the
bacterial communities in each mouse for each time period, and
how they shifted in response to the antibiotics and during the
recovery period (Figures 2A,B). The pre-TZP time points are
tightly clustered together, indicating that all mice had very similar
microbiomes prior to antibiotic exposure. Upon antibiotic exposure,
the taxonomic profiles split into two clusters. The cluster at the
bottom right of the graph consists of mice that had 50%–100%
relative abundance of a single OTU that was classified in the
order Clostridiales, but did not match sequences in databases
at lower phylogenetic levels. Mice that fit this profile are indicated
by a closed circle. All other mice (<50% Clostridiales) are
indicated with open circles, and the taxonomic profiles for the
antibiotic time point (red) for those mice cluster in the upper
right portion of the graphs. As the mice entered the recovery
period, the Clostridiales-dominant and other mice clusters began
to shift closer together again, indicating a more similar profile.

As the OTU clustering was performed separately for each
experiment, a joint analysis of the two experiments was performed
at the genus level, using the taxonomic classifications assigned
to each OTU using RDP classifier. Figure 2C shows a joint
PCoA plot of both TZP1 and TZP2 based on the Bray-Curtis
distance matrix of their respective genera profiles. For each pre-,
during, and post-TZP period, the graph shows that the three
treatments clustered separately. However, the closed (TZP1) and
open (TZP2) circles are intermingled, showing that the taxonomic
profiles and their antibiotic-induced shifts are reproducible.
The changes in community structure of the combined data
sets were measured for each time point, assessing richness
(total taxa), evenness (uniformity of abundances of taxa), and
using the Shannon diversity index, which considers both
evenness and richness (Figure 3). Upon antibiotic exposure,
the diversity dropped significantly (p = 0.0012 between days
6 and 13 for TZP1 and p = 2.83 × 10−6 between days 14 and
18 in TZP2, using Fisher’s T-Test). The diversity continued
to decrease within 1 week after TZP treatment (p = 0.0002
between days 14 and 20 in TZP1 and p = 7.22 × 10−10 between
days 19 and 25 in TZP2), and began to recover 2 weeks
post-TZP treatment in TZP2, though still significantly different

A

B

C

FIGURE 2 | Principal coordinate analysis (PCoA) of taxonomic profiles. PCoA analysis based on the Bray-Curtis distance matrix of OTUs from TZP1 (A) and TZP2
(B) experiments. Each circle represents a single mouse at a single time point. Closed circles represent mice that had >50% Clostridiales (OTU-1 in A, OTU-3 in B) at
any time point and open circles represent all other mice. (C) PCoA analysis on Bray-Curtis distance matrix based on combined genera profiles from both
experiments. Note that the number of bullets per panel may vary as a consequence of the number of mice per group and the number of samples taken and
analyzed in full per individual mouse.
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FIGURE 3 | Effect of piperacillin-tazobactam (TZP) on the Alpha Diversity. The alpha diversity of each mouse in each time point was measured using Pielou’s
evenness, absolute number of OTUs (richness), and Shannon diversity index (diversity). Significant differences between two time points are indicated by asterisks
where p > 0.05 = ns, p < 0.05 = *, p < 0.01 = **, p < 0.001 = ***, and p < 0.0001 = ****. Panel (A) shows results obtained during the TZP1 study, whereas panel
(B) displays the results obtained during the TZP2 study.

Species Composition

from the pre-TZP time point (p = 6.77 × 10−8). Diversity recovery
was not observed in TZP1 as it was terminated 1 week postTZP. The evenness of the taxa prior to TZP treatment was
tightly associated, with all mice having similar evenness. During
and post-TZP treatment, the evenness was more widespread
across the different mice, with some having less evenness
than others. Still, a significant decrease in the mean evenness
was observed, as expected if dominant organisms emerged,
with the lowest mean occurring at 1 week post-treatment
(p = 0.0232 and 7.22 × 10−10 between days 15 and 20, and 19
and 25, in TZP1 and TZP2, respectively). Richness significantly
decreased upon antibiotic treatment, consistent with the decrease
in bacterial load, and remained significantly lower than the
pre-antibiotic state up through the end of TZP2, 3 weeks postantibiotic (p = 3.80 × 10−15 between days 19 and 39). As noted
above, there do not seem to be significant differences between
immune-competent and neutropenic mice.

The top 25 taxa are plotted in Figure 5A to show the relative
abundance of each taxon at each time point for each mouse.
Taxa composition in the pre-TZP time points was more diverse
than during and immediately after the TZP treatment. A
single OTU was predominant in some mice during and
post-TZP treatment. The microbiota in several mice were
dominated by unclassified Clostridiales (OTUs 1 and 3 in
Figures 5A–C, respectively; for similar data obtained for
TZP1 see Supplementary Figures 3A–C, 4).
In addition to these proportionately dominant taxa, we studied
if any minor organisms showed enrichment after antibiotic
treatment. To determine if the antibiotic treatment selected
for or promoted the growth of certain organisms, we calculated,
for each OTU, the relative abundance during the antibiotic
treatment and immediately after treatment, compared to the
last pre-TZP time point. There were 15 OTUs that increased
in one or two mice (Supplementary Figures 5A,B); OTUs 1
and 3 increased in many more mice (Figures 5B, 6). Since
these data only show the relative abundance and do not
indicate whether the bacteria were in fact increasing in absolute
numbers during these time points, qPCR was performed on
samples from TZP1 with custom primers specific to the
OTU-1 V1–V3 region (Figure 7). The bacterial load of this
OTU increased in several mice, including mouse 6, one of
the two mice that had ~100% relative abundance of this
OTU during days 9 and 13. However, the absolute abundance
of this organism was in general low, and difficult to accurately
quantify. We were not able to grow these bacteria when
samples from TZP1 were cultured on TZP chromID plates,
most likely since Clostridiales are anaerobic and non-capable
of growing in the presence of excessive oxygen. Subsequent
efforts to recover these bacteria from frozen stool pellets
were also unsuccessful.

Changes in Overall Community Structure

In addition to significant changes in alpha diversity and taxonomic
profiles, we also observed changes to the overall community
structure. Plotting the OTUs by their ranked abundance, the
pre-TZP time points exhibited a community structure with
all taxa at less than 0.5% abundance and over 75 taxa detectable
for ranking (Figure 4). Upon TZP treatment, the community
shifted dramatically with some taxa present at 0.5%–1%
abundance and less than 30 ranked taxa, similar to the
observations for OTU richness. In the immediate post-TZP
time points, some mice experienced shifts in their microbiota
with more ranked taxa present, although this trend appeared
in few mice and was unstable in the later time points during
recovery. These results may indicate a fluctuating community
structure where a dominating organism may change over time,
as reported in environmental samples (Ofiteru et al., 2010).
Frontiers in Microbiology | www.frontiersin.org
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A

B

FIGURE 4 | Bacterial community structure. The OTUs for all mice in each experiment (TZP1 in A, TZP2 in B) are plotted by ranked abundance for each time point.

Full-Length 16S rRNA Sequencing for
Predominant Species

This family is newly proposed for the clade of Clostridium 16S
III taxa that were previously in the Ruminococcaceae family
but are phylogenetically distinct. Given its branch length and
low percent identity to other taxa, we believe this is a new
genus and species that has not yet been described. Its closest
matches are Eubacterium siraeum (branch below) and
Mageeibacillus indolicus and Saccharofermentans acetigenes (branch
above). Eubacterium siraeum has brackets around the genus name
because NCBI noted that the genus is still awaiting reassignment.
It is thought that this taxon belongs to the Hungateiclostridiaceae
family, mostly isolated from the human GI tract. The M. indolicus
and S. acetigenes were both recently discovered spore-formers
from the vaginal microbiome (Austin et al., 2015).

Representative sequences from the top 10 OTUs from three
mice per sequence motif were all highly similar. Bootstrap values
are shown next to each node in the phylogenetic tree that was
built around these 16S sequences with each label colored by
family (Figure 8). The representative sequences of the top 10
full-length 16S rRNA gene OTUs cluster together in the middle
of the tree (labeled as representative sequence 1–10). Surrounding
reference sequences were the best BLAST hits from GenBank’s
RefSeq collection and the labels include the order, family, genus,
and species. It appears that the organism belongs to the Clostridiales
order, in the Hungateiclostridiaceae family (Zhang et al., 2018).
Frontiers in Microbiology | www.frontiersin.org
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FIGURE 5 | Taxonomic profiles. The relative abundance of taxa is represented by stacked bars for each mouse and each day. The top 25 OTUs are colored
individually and all other OTUs are assigned to the “Other Taxa” group (light gray). (A) Portrays TZP1 in which TZP was administered days 7–13, (B,C) portray
immunocompetent mice (mice 1–10) and neutropenic mice (mice 11–20), respectively, from TZP2 in which TZP was administered on days 15–18.

Immune-Competent vs. Neutropenic Mice

studied. A PCoA plot based on the Bray-Curtis distance matrix
of the OTU profiles for each mouse in TZP2 was generated with the
closed circles representing immunocompetent mice and open

The possibility that the microbiota shift in response to the antibiotic
might differ in immunocompetent and neutropenic mice was
Frontiers in Microbiology | www.frontiersin.org
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FIGURE 6 | Resistant Clostridiales OTUs. The fold change of relative abundance of Clostridiales OTUs 1 and 3, (A,B, TZP1 and TZP2, respectively) compared to
the last pre-antibiotic time point (Days 6 and 14, respectively) are plotted for each day. The vertical line indicates the approximate first TZP exposure. Mice 1–10
were immunocompetent while mice 11–20 were neutropenic.

FIGURE 7 | OTU-1 Abundance. Absolute abundance of OTU-1 in TZP1 estimated by targeted qPCR.

circles representing neutropenic mice (Supplementary Figure 2).
At each of the pre-, during, and post-TZP time points the closed
and open circles are intermingled, showing that the
cyclophosphamide-affected immune status of the mice does not
appear to have a major effect on the microbiota changes. This
leads us to conclude that the immediate, short-term effect of
cyclophosphamide on the gastro-intestinal flora of mice is apparently
negligible. Longer term effects have not yet been assessed here
but obviously warrant additional studies.

experiment (Supplementary Figures 6, 7). Experiments were
performed to confirm the concentration as well as track the
levels of the piperacillin post-treatment. Between 2 and 7 days
after discontinuation of treatment, the piperacillin concentration
generally decreased by a factor of 1,000 on average.

Metabolomic Analyses

Supervised PCoA score plots without weighting and Pareto
scaling were performed on the metabolomics data. Score plots
for PC1 and PC2 of the overall QTOF MS features, found in
positive ion mode, show good separation of on-TZP vs. off-TZP
animals (red symbols in Figure 9). The on-TZP samples clustered
together for both immune-competent and neutropenic mice,
again showing the lack of significant differences between the

Piperacillin Levels in the Fecal Samples

The level of piperacillin in the feces was determined by HPLC
of samples from each mouse on days 13 and 20 for the first
experiment, and days 15, 18, 19, and 20 for the second
Frontiers in Microbiology | www.frontiersin.org
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FIGURE 8 | Phylogenetic tree for the newly discovered dominating species in some of the mice post antibiotic treatment.

groups as was also demonstrated at the bacterial taxon levels.
The pre-TZP and post-TZP samples were grouped in the left
quadrant of the plot with post-TZP components in the upper
left and the pre-TZP in the quadrant below separating the two
treatment groups. The pre-TZP and post-TZP components also
Frontiers in Microbiology | www.frontiersin.org

correlate well on a linear basis. Score plots of PC1 and PC3,
defined in negative ion mode show similar patterns but with
more specific clustering of both treatment groups. Spectral features
that cluster due to TZP exposure were captured while comparing
the pre-TZP group with the other sample groups. Score plotting
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FIGURE 9 | Metabolomic profiling. Principal component analysis of non-targeted TripleTOF mass spectrometer (MS) data of mouse feces successfully grouped
treatment from non-treatment mice. The scores plot for PC1 and PC3 of MS features in positive ion mode shows good separation of the antibiotic vs. non-antibiotic
time points. Furthermore, clusters of post-antibiotic immunocompetent and post-antibiotic neutropenic features also show good separation from each other with
immunocompetent clustering above and neutropenic below the x-axis.

DISCUSSION

of PC3 and PC4 quantifies the variance between immunecompetent and neutropenic mice, which again is non-significant.
In conclusion, metabolomic analyses were performed on the
fecal pellets from the second experiment mostly to look for
changes in metabolites. Metabolomic profiling of each mouse
showed that the metabolomes of mice pre-TZP were similar
and the metabolomes during TZP exposure were also similar
(Figure 9). The post-TZP metabolomes of mice were separated
based upon whether the mouse was immune-competent or
neutropenic, something the bacterial taxonomy tests could not.
Overall, there is good congruency between taxonomic and
metabolomic analyses. Currently, it is unclear which fraction
of the metabolomic markers is of microbial vs. human origin.
Also, we have not been able to detect and quantify short chain
fatty acids (SCFA) and bile acids, molecules known to be of
eminent biological relevance in microbiome modelling. Further
studies into the relevance of these two categories of molecules
on the dynamics of our model are still required.
Frontiers in Microbiology | www.frontiersin.org

Further data assembly and interpretation is needed to identify
the precise bacterial species and associated metabolomic features,
which play major roles in the antibiotic response in gut microbiome.
Many medical treatments have a major effect on the composition
of the human microbiome (e.g., Minalyan et al., 2017 or Shukla
et al., 2019). This mostly involves antibiotics but other commonly
used drugs may produce distinct effects as well (Maier et al.,
2018). Whether such disturbances are short-term and whether
microbiomes return to their original state after antibiotic treatment
are currently ill-defined (Dethlefsen and Relman, 2011; Nobel
et al., 2015). In rat and mouse models, however, it has been
demonstrated that changes in the microbiome depend on the
type of antibiotic (Tulstrup et al., 2015) and the microbiome
composition may pre-dispose toward susceptibility to certain types
of controlled infection (Theriot et al., 2014; Koo et al., 2019).
Volunteer studies in humans showed that, in part, depending on
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the initial status of GI flora diversity, common species may
disappear upon antibiotic treatment and not recover (Dethlefsen
et al., 2008; Raymond et al., 2016a,b; Palleja et al., 2018). TZP
treatment in humans undergoing hematopoietic stem cell
transplantation caused severe declines in cell counts for gastrointestinal obligate anaerobes (Morjaria et al., 2019). Although these
studies concluded that bacterial diversity was usually restored
relatively quickly after treatment, there is continuing lack of clarity
as to the short-term effects of enrichment of resistant organisms
in the GI tract and the long term effects of the remaining flora
changes (Roodgar et al., 2021). Jakobsson et al. (2010), for instance,
were able to show that anti-Helicobacter pylori treatment may
have consequences on the flora of the throat and GI that may
last for years and lead to enrichment of resistance genes. This
finding reveals a serious side effect of antibiotic usage, as resistance
genes can cross species barriers while residing in the GI flora
(Shoemaker et al., 2001). In specific patient cohorts, personalized
prediction of the effect of antibiotic treatment will require combined
interpretation of microbiome, resistome, and even mobilome data
(Willmann et al., 2019). We here show reproducible restoration
effects in individual mice after TZP treatment on the composition
and bacterial density of the gastro-intestinal flora in a standardized
mice model of antibiotic treatment. Still, we do observe heterogeneity
in the flora restoration patterns between different mouse individuals,
although less than among humans. Hence, we feel that the model
proposed here is going to be helpful in defining early detrimental
effects of antibiotic treatment and their later effect on restoration
of flora diversity. Different antibiotics can be used in combination
with different mouse genotypes whereas also external factors
including diet can be modulated contemporaneously.

mentioned above mainly displays the dominant expansion of a
single bacterial species, which is likely a new one that should
be integrated into the Mouse Intestinal Bacterial Collection
(Lagkouvardos et al., 2016). In several mice, this single species
dominated the post-antibiotic flora. It would be interesting to
study whether the different profiles lead to different health
consequences post-treatment and whether or not restoration of
the flora is equally feasible after either of the two format changes.
All findings were reproducible between experiments.

Metabolomic Variation Upon Antibiotic
Treatment

The variation and dynamics of bacterial cell counts and taxa
mentioned above can be noted at the level of the metabolome
as well, showing an intricate association between the complexities
of the microbiomes and the metabolomes (Nobel et al., 2015;
Yachida et al., 2019). For that reason, coupled investigation on
the diversity and dynamics of both entities are mandatory. Initial
studies in a mouse model for Clostridioides difficile infection
(CDI) already showed a tight correlation between changes in
the gastro-intestinal flora and the presence and concentration
of bile metabolites and low molecular weight carbon sources
(Theriot et al., 2014). In humans, metabolomics allowed for the
distinction of fecal metabolomes for individuals with CDI, patients
with non-C. difficile diarrhea and those with mere C. difficile
colonization (Robinson et al., 2019). Here we confirm a close
correlation between the two also in our standardized mouse
model. Further interpretation is needed to identify the precise
MS-defined metabolome features and determine which specific
molecules play a role in gut microbiome health and recovery
after antibiotic treatment. Inclusion of the dietary composition
has been shown to be important as well (Cabral et al., 2019)
and our mouse model would allow detailed studies on the impact
of changes in an otherwise homogeneous diet provided. Quantitative
analysis can then be performed on the identified small molecules
of interest to access potential biomarkers. Identification of the
molecules, whether host-or microbiome-derived, may result in
approaches that might help restore the GI flora in its initial
format. It has already been demonstrated that the effects of
antibiotic treatment in humans at the level of the metabolome
may be more rapidly detectable than effects at the level of the
microbiota (Vrbanac et al., 2020). This may have a significant
impact on the development of microbial diagnostics reflecting
changes in resident microbial flora in a range of eukaryotic hosts.

The TZP Model

We here define a non-infectious mouse model potentially suited
for extrapolation regarding the use of antibiotics in humans since
we use a humanized dosing schedule. Still, TZP is associated with
a complicated variety of selective features. It selects for beta-lactamase
hyper-producers and may help enrich multiple beta-lactamase types.
The simple switch to alternative antibiotic classes will not easily
result in reversion of resistance (Lee et al., 2013). Also, novel
resistance mechanisms toward TZP are still being discovered
(Schechter et al., 2018). Fortunately, we did not find obvious
changes in phenotypic TZP resistance levels during our relatively
short term experiments. Studies with other antibiotics and with
longer treatment duration should shed more light on the emergence
of resistance. Also, attempts to cultivate new species using strictly
anaerobic culture methods and media were unsuccessful.
The gastro-intestinal bacterial load dropped significantly upon
antibiotic exposure, exhibiting a slight recovery post-antibiotic
treatment. We observed that the flora changes during and after
TZP treatment can be reproduced between experiments. This
suggests that the model is robust, although we have been using
limited numbers of mice thus far. In addition, TZP treatment
pushes the flora into two dynamic directions, clearly visible in
our diversity plots and partial ribosomal sequencing data. Two
distinct taxonomic profiles were observed during and after antibiotic
exposure, where mice had either predominantly Firmicutes or
a more diverse mix of taxa in their feces. One of the profiles
Frontiers in Microbiology | www.frontiersin.org

CONCLUSION
We present a mouse model of humanized TZP treatment
allowing for longitudinal screening of (changes in) GI microbiome
diversity. We observe two major taxonomic profiles over time,
one that is composed of more diverse flora and another one
where a new bacterial species dominates the flora. The presence
of this species results in a less complete restoration of the
flora after TZP treatment. The bacterial variation over time
is not significantly different between immune-competent and
neutropenic mice, although metabolomic data differentiate
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between the two. The model is ready for further research into
development of resistance and the analysis of long-term effects
of the various microbiome evolutions on overall health of the
model animals. Hopefully, data obtained in this standardized
way can lead to extrapolation toward the human ecosystem
and stimulate innovative translational research.

Supplementary Figure 1 | Bacterial quantification of the TZP1 experiment. Box
and whiskers plots show the fold change of the 16S rRNA gene count as
generated by qPCR from DNA extracted from stool for all mice at each time point
as compared to Day 8, the timepoint immediately prior to antibiotic treatment.
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Supplementary Figure 3 | (A) Phyla profiles. The relative abundance of the
phyla is represented by stacked bars for each mouse and each day. (A) Portrays
TZP1 in which TZP was administered days 7–13, (B,C) portray
immunocompetent mice (mice 1–10) and neutropenic mice (mice 11–20),
respectively, from TZP2 in which TZP was administered on days 15–18. (B,C)
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Supplementary Figure 2 | PCoA of taxonomic profiles and immune status.
PCoA analysis based on the Bray-Curtis distance matrix of OTUs from TZP2.
Each circle represents a single mouse at a single timepoint. Closed circles
represent immunocompetent mice and open circles represent neutropenic mice.
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“Other Taxa” group (light gray). (A) Portrays TZP1 in which TZP was
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neutropenic mice (mice 11–20), respectively, from TZP2 in which TZP was
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top 25 genera are colored individually and all other genera are assigned to the
“Other Taxa” group (light gray). (A) Portrays TZP1 in which TZP was
administered days 7–13, (B,C) portray immunocompetent mice (mice 1–10) and
neutropenic mice (mice 11–20), respectively, from TZP2 in which TZP was
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AUTHOR CONTRIBUTIONS
All authors listed have made a substantial, direct, and intellectual
contribution to the work, and approved it for publication.

Supplementary Figure 5 | (A) Potentially Resistant OTUs. OTUs that
underwent a positive fold change of relative abundance post-TZP exposure are
shown for each experiment (A,B, TZP1 and TZP2, respectively). Fold change was
calculated compared to the last pre-antibiotic time point (Days 6 and 14,
respectively). The vertical line indicates the approximate first TZP exposure. (B,C)
Potentially resistant OTUs. OTUs that underwent a positive fold change of relative
abundance post-TZP exposure are shown for each experiment (A,B, TZP1 and
TZP2, respectively). Fold change was calculated compared to the last preantibiotic time point (Days 6 and 14, respectively). The vertical line indicates the
approximate first TZP exposure.
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Supplementary Figure 7 | Piperacillin concentrations in mouse feces during
and post-TZP exposure.
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